| Generic Name | Omeprazole |
|---|---|
| Drug Class | Proton Pump Inhibitor |
| Indications |
|
| Mechanism of Action | Irreversibly inhibits the H+/K+-ATPase proton pump in gastric parietal cells, leading to profound suppression of gastric acid secretion. |
| Available Forms & Strengths | • Capsule / Tablet: 20 mg, 40 mg • Oral suspension • IV injection: 40 mg |
| Dosage | Adults: 20–40 mg once daily (before meals) Children: 0.7–1 mg/kg once daily (max 40 mg) |
| Route | Oral, IV |
| Common Side Effects |
|
| Serious Adverse Effects | Hypomagnesemia, vitamin B12 deficiency, C. difficile infection, increased fracture risk (long-term use) |
| Contraindications | Hypersensitivity to omeprazole or other PPIs |
| Precautions | • Long-term therapy • Hepatic impairment • Osteoporosis risk |
| Drug Interactions | • Clopidogrel (↓ antiplatelet effect) • Warfarin • Phenytoin • Diazepam |
| Pregnancy & Lactation | Pregnancy: Generally considered safe Lactation: Use with caution |
| Storage | Store below 30°C, protect from moisture |
| References | BNF | BNF for Children | Goodman & Gilman |